A Study of QBI-139 in Subjects With Advanced Solid Tumors
NCT00818831
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
QBI-139
Sponsor
Quintessence Biosciences, Inc.